A Practical Process for Obtaining Reimbursement

As specialized medical device reimbursement consultants backed by a 20-year track record and specialized expertise from former Medicare, Medicaid, and private health insurance Medical Directors, we don't just plan pathways, we execute them. Developing a proactive medical device reimbursement strategy is critical to bridging the 'Valley of Death' between regulatory clearance and commercial revenue, ensuring your device is fully coded, covered, and paid across global healthcare networks.

Many startups assume FDA clearance or CE markings guarantee adoption, only to find that insurance companies, regional MACs, and European sickness funds demand separate health economic and clinical evidence profiles.

Activity Description Phase May Impact
1. Reimbursement Landscape
a. Money flows and financial incentives
b. Reimbursement mechanisms
c. Decision makers and strategy
 R&D
Features and applications
Predicate device / intended use
Price
Explore Landscape Services
2. Reimbursement Planning
a. Value story
b. Economic model
c. Support of clinical data
d. Feedback from decision makers
 Pre Clinical
Clinical study protocol
Business case
Market size
View Planning & Strategy
3. Obtaining Reimbursement (Implementation)
a. Billing guides and Dossier submission
b. Securing local medical community support
c. Prior authorizations and denial appeals
d. Direct negotiations and pilot projects with payers
e. Establishing new reimbursement mechanisms (NUB, Liste en Sus)
 Pre-Sales & Launch
Time to Revenue
Cash Flow Sustainability
Exit Valuation
How we obtain reimbursement

Interactive Reimbursement Runway Explorer

Adjust your regulatory strategy and country targets below to simulate your projected commercial timeline and identify potential market access roadblocks before they impact your company valuation.

Target Market
Region

Regulatory
Pathway

Health Economic
Evidence Strategy

Total Time to First Cash 6 Months
Pre-Revenue Commercial Risk High Risk
Regulatory Pathway Timeline (Baseline Estimate) 6 Mo
Mediclever Reimbursement Strategy & Implementation Track 0 Mo
0 Months (Project Kickoff) 12 Months 24 Months 36+ Months

Ready to start your reimbursement planning?

Why Leading Firms Choose Mediclever for Medical Device Reimbursement Strategy

Strategic Healthcare Reimbursement Consulting

Developing a reimbursement strategy for medical devices requires more than just clinical data; it requires an understanding of how payers value innovation. As your medical device reimbursement consultant, we align your clinical trial endpoints with the economic evidence payers demand.

Navigating Complex Reimbursement for Medical Devices

The "Valley of Death" is often caused by a lack of coding, coverage, and payment. Our team acts as your global reimbursement medical devices experts, handling direct negotiations with sickness funds in Germany, HAS submissions in France, and Medicare/Payer coverage in the US.

"A regulatory clearance (FDA/CE) is a license to sell, but a reimbursement code is a license to get paid."

Medical Device Reimbursement Services by Country

Navigating localized healthcare economics, national health technology assessments (HTA), and regional fee schedules across major commercial corridors.

Frequently Asked Questions for Medical Device Reimbursement

What do medical device reimbursement consultants do?

A medical device reimbursement consultant helps manufacturers secure coding (identifying the product), coverage (the payer's decision to pay), and payment (the actual dollar amount) for new technologies. We bridge the gap between technical innovation and commercial healthcare viability by translating clinical trial datasets into verifiable value statements for economic buyers and insurance medical directors.